drugset
drugset / Trial / NCT07799090

Pharmacokinetic Study of GB-5001A 280 mg Long Acting Injection, in Comparison With the Comparator Drug Aricept® 5 mg and Aricept® 10 mg Film-coated Tablet in Healthy Subjects

NCT07799090 ↗

Phase 1 Completed 28 enrolled G2GBio, Inc. PT Equilab International · collab
RandomizedParallel-groupOpen-labelBasic science

Summary

This study is to find out whether the bioavailability of GB-5001A 280 mg Injection is compared to the comparator drug of Aricept® 5 mg and Aricept® 10 mg which are Film-Coated Tablet when administered in healthy subjects. Also to monitor the adverse events and to ensure the safety of the subjects.

Timeline

Start
2025-08-12
Primary completion
2026-04-15
Completion
2026-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule 5 mg Oral
Subject Donepezil Small molecule 10 mg Oral
Subject GB 5001A Unknown 280 mg —

Indications

No indication recorded.